Sociedad Americana de Hirudoterapia

Updates in Wound Management and Dressings

Research article published in The Veterinary clinics of North America. Small animal practice (2022)

Última actualización: March 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Genómica y proteómicaEnsayos clínicosBuote N · The Veterinary clinics of North America. Small animal practice, 2022

Abstract

Wound healing is a complex process that traverses 4 main phases which overlap and are interdependent. Many patient-related factors can impede healing by disrupting the normal pathways from one phase to the next. Wound-related factors also determine the best techniques or dressings for each patient. Species differences between cats and dogs must be understood for the successful treatment of cats. New techniques such as fish skin graft application, photobiomodulation, and bioelectric dressings hold promise as an addition to our armamentarium against wounds. NPWT, hyperbaric oxygen, regenerative medicine techniques, and low-level laser therapies yield mixed results and large-scale controlled studies are needed.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleReview
Indexed MeSH termsAnimalsBandagesCatsDogsSkin TransplantationWound Healing

Resumen

Wound healing is a complex process that traverses 4 main phases which overlap and are interdependent. Many patient-related factors can impede healing by disrupting the normal pathways from one phase to the next.

Por qué esto importa para la hirudoterapia

Expands the genomic and molecular understanding of medicinal leeches and their bioactive repertoire.

Citación

Updates in Wound Management and Dressings.

Buote N · The Veterinary clinics of North America. Small animal practice, 2022

Contexto clínico relacionado

Añadido a la biblioteca ASH: March 18, 2026 · Última actualización del sitio: March 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.

Updates in Wound Management and Dressings | ASH